In conclusion, our data demonstrate that high CapG level is associated with poor RFS and non-pCR in breast cancer patients received PTX-based chemotherapy, which at least in part are owing to increased activation of PI3K/Akt pathway. The gene discussed is PIK3CA; the disease is breast carcinoma.